EIKO LIFESCIENCES LIMITED

BSE: EIKO540204ISIN INE666Q01016

Commodities
Specialty Chemicals

Share price

₹50.81-0.22 (-0.43%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹64.44
52W low: ₹43.00
Off 52W high: -21.15%
1M return: +6.81%
3M return: +0.89%
6M return: +1.30%
1Y return: -18.09%
20D avg volume: 8,385
50 DMA: ₹48.12
200 DMA: ₹50.15

Key ratios Consolidated

Market cap: ₹74.44 Cr
Current price: ₹50.81
52W high / low: ₹64.44 / ₹43.00
Face value: ₹10.00
P/E: 13.03
P/B: —
EPS (TTM): ₹3.90
Book value / share: —
ROE: —
ROCE: 10.00%
Operating margin: —
Net margin: —
Debt / equity: 0.07
Net debt: ₹-8.88 Cr
Interest cover: 22.42
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 80.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	16.75	18.34	11.98	11.67	10.71	11.27	7.49	8.15	10.75	—
	0.41	0.13	0.32	0.26	0.27	0.23	0.09	0.13	0.26	—
	17.16	18.47	12.30	11.93	10.98	11.50	7.58	8.29	11.01	—
	15.20	16.42	10.43	10.26	9.50	10.28	7.04	7.93	10.55	—
	13.94	16.66	9.01	10.16	5.46	12.00	6.27	6.86	9.92	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.20	0.21	0.20	0.14	0.13	0.11	0.14	0.07	0.13	—
	0.13	0.12	0.07	0.10	0.05	0.07	0.03	0.04	0.17	—
	0.25	0.25	0.26	0.26	0.25	0.25	0.16	0.16	0.03	—
	1.08	0.78	0.70	1.05	0.77	0.73	0.29	0.47	—	—
	1.96	2.05	1.87	1.67	1.48	1.23	0.54	0.35	0.46	—
	0.00	0.00	0.00	0.00	0.00	0.34	0.00	0.00	0.00	—
	1.96	2.05	1.87	1.67	1.48	1.57	0.54	0.35	0.46	—
	0.49	0.52	0.48	0.43	0.37	0.39	0.14	0.10	0.12	—
	1.51	1.50	1.43	1.28	1.12	1.24	0.42	0.28	0.37	—
	0.91	0.93	0.88	0.78	0.66	0.80	0.32	0.22	0.29	—
Key metrics
	2.34	2.42	2.20	2.03	1.78	1.89	0.73	0.55	0.66	—
	14.00%	13.20%	18.40%	17.40%	16.60%	16.80%	9.70%	6.70%	6.10%	—
	9.00%	8.20%	11.90%	11.00%	10.50%	11.00%	5.60%	3.40%	3.40%	—
	—	2.90%	—	2.90%	—	2.70%	—	—	—	—
	56.40%	62.70%	59.90%	43.20%	-0.40%	—	—	—	—	—
	34.80%	21.00%	240.50%	357.10%	202.70%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	58.74	52.71	37.66	—
	1.12	0.97	0.72	—
	59.86	53.68	38.38	—
	52.31	46.62	35.80	—
	49.77	41.28	35.04	—
	0.00	0.00	0.00	—
	0.75	0.67	0.37	—
	0.42	0.33	0.16	—
	1.02	1.02	0.74	—
	3.61	3.31	1.88	—
	7.55	7.07	2.58	—
	0.00	0.00	0.34	—
	7.55	7.07	2.92	—
	1.92	1.79	0.75	—
	5.72	5.33	2.32	—
	3.50	3.26	1.62	—
Key metrics
	8.99	8.42	3.82	—
	15.30%	16.00%	10.10%	—
	9.74%	10.10%	6.20%	—
	—	10.00%	5.10%	—
	56.14%	40.00%	—	—
	86.93%	129.70%	—	—
	—	2.28	-7.37	—
	—	0.43	1.26	—
	—	0.07	0.05	—
	—	-8.88	-9.01	—
	—	80.5	128.4	—
Balance sheet
	—	89.37	66.10	—
	—	47.41	32.88	—
	—	13.61	11.78	—
	—	20.22	10.79	—
	—	3.97	5.77	—
	—	9.60	4.54	—
	—	22.10	23.12	—
	—	12.56	3.31	—
	—	15.38	6.27	—
	—	4.73	2.77	—
	—	1.67	0.76	—
	—	3.06	2.01	—
	—	69.82	57.01	—
Cash flow
	—	2.28	2.92	—
	—	-8.66	-11.44	—
	—	8.21	6.96	—
	—	0.00	10.29	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	14.18	15.90	9.57	9.20	7.45	7.09	6.91	7.74	10.75	—
	0.68	0.45	0.56	0.56	0.55	0.53	0.10	0.13	0.26	—
	14.86	16.36	10.13	9.76	8.01	7.62	7.01	7.87	11.01	—
	13.46	14.87	8.89	8.69	7.10	6.76	6.63	7.59	10.55	—
	13.24	15.87	8.18	8.63	4.60	7.35	5.94	6.61	9.92	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.07	0.07	0.09	0.07	0.06	0.06	0.11	0.06	0.13	—
	0.04	0.04	0.04	0.07	0.02	0.04	0.02	0.04	0.03	—
	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.16	0.17	—
	0.36	0.33	0.22	0.34	0.31	0.28	0.25	—	—	—
	1.40	1.49	1.24	1.07	0.91	0.85	0.38	0.28	0.46	—
	0.00	0.00	0.00	0.00	0.00	0.34	—	—	—	—
	1.40	1.49	1.24	1.07	0.91	1.20	0.38	0.28	0.46	—
	0.34	0.37	0.30	0.25	0.22	0.29	0.10	0.07	0.12	—
	1.06	1.12	0.95	0.82	0.69	0.90	0.28	0.21	0.35	—
	0.74	0.80	0.69	0.60	0.50	0.69	0.24	0.16	0.27	—
Key metrics
	1.59	1.68	1.43	1.29	1.08	1.39	0.55	0.48	0.66	—
	11.20%	10.60%	14.90%	14.00%	14.50%	19.60%	8.00%	6.20%	6.10%	—
	7.50%	7.00%	9.90%	8.90%	9.30%	12.70%	4.10%	2.70%	3.30%	—
	—	2.20%	—	1.90%	—	2.10%	—	—	—	—
	90.30%	124.30%	38.50%	18.90%	-30.70%	—	—	—	—	—
	53.60%	24.40%	239.30%	290.50%	97.10%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	48.85	42.13	32.49	—
	2.25	2.13	1.02	—
	51.11	44.26	33.52	—
	45.91	39.54	31.54	—
	45.92	37.28	29.83	—
	0.00	0.00	0.00	—
	0.30	0.29	0.28	—
	0.19	0.16	0.13	—
	0.60	0.59	0.63	—
	1.25	1.20	1.29	—
	5.20	4.71	1.98	—
	0.00	0.00	0.34	—
	5.20	4.71	2.32	—
	1.26	1.13	0.58	—
	3.95	3.58	1.74	—
	2.83	2.60	1.34	—
Key metrics
	5.99	5.46	3.08	—
	12.26%	13.00%	9.50%	—
	8.09%	8.50%	5.40%	—
	—	7.10%	4.20%	—
	67.35%	29.70%	—	—
	89.90%	105.70%	—	—
	—	6.92	0.72	—
	—	1.93	1.18	—
	—	0.02	0.03	—
	—	-11.88	-9.75	—
	—	90.4	146.6	—
Balance sheet
	—	82.79	60.37	—
	—	38.45	28.42	—
	—	13.55	11.51	—
	—	18.89	10.14	—
	—	3.97	4.02	—
	—	2.04	2.75	—
	—	13.67	14.26	—
	—	12.43	1.11	—
	—	14.53	2.27	—
	—	1.67	1.76	—
	—	1.67	0.76	—
	—	0.00	1.00	—
	—	67.50	56.42	—
Cash flow
	—	6.92	2.05	—
	—	-11.21	-9.85	—
	—	6.33	5.97	—
	—	0.00	1.33	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +67.35%
Profit YoY (TTM): +89.90%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +56.14%
Profit YoY (TTM): +86.93%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 39.96%

Quarter	September 2026	June 2026
Promoter %	39.96%	39.91%

Holder	Type	Holding	Previous	Change
LENUS FINVEST PRIVATE LIMITED	Promoter Group	17.34%	17.71%	-0.37%
LAXMIKANT KABRA (HUF)	Promoter Group	9.69%	9.90%	-0.21%
2B BLACK BIO LLP .	Public	9.64%	9.66%	-0.02%
BHAVESH DHIRAJLAL TANNA	Promoter	6.62%	5.86%	+0.76%
SIDDHANT LAXMIKANT KABRA	Promoter Group	5.51%	5.63%	-0.12%
ASHIKA GLOBAL FINANCE PVT. LTD.	Public	4.16%	—	—
ASHOK VISHWANATH HIREMATH	Public	3.64%	3.72%	-0.08%
SUSHILA PARASKUMAR DAGA	Public	2.72%	2.78%	-0.06%
SIVANESAN SELLAPPAN	Public	1.98%	2.02%	-0.04%
JOYANTA KUMAR JANA	Public	1.95%	1.99%	-0.04%
PARSHVA KUMAR DAGA	Public	1.64%	1.68%	-0.04%
BHAVINKUMAR VINAYCHAND SHAH	Public	1.32%	1.35%	-0.03%
V Square Pharmachem Private Limited	Public	1.19%	—	—
KAUSHIK DAGA	Public	1.08%	1.11%	-0.03%
LAXMIKANT RAMPRASAD KABRA	Promoter	0.80%	0.81%	-0.01%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Pidilite Industries Ltd.	1,57,375	1,507.00	56.47	28.50%	+16.83% TTM	+20.94% TTM	+3.57%
Gujarat Fluorochemicals Limited	51,706	4,612.90	75.63	10.10%	+20.33% TTM	-1.47% TTM	+25.63%
Navin Fluorine International Limited	45,270	8,785.00	49.50	18.70%	+45.68% TTM	+105.04% TTM	+45.12%
Deepak Nitrite Limited	21,067	1,580.65	20.29	10.80%	+23.80% TTM	+99.83% TTM	-9.73%
Aether Industries Limited	20,608	1,542.85	82.16	12.20%	+30.76% TTM	+28.03% TTM	+103.85%
Aarti Industries Ltd	16,086	449.65	27.46	8.50%	+39.85% TTM	+104.40% TTM	+16.66%
Fine Organic Industries Limited	15,854	5,127.35	38.71	20.20%	+12.92% TTM	+18.80% TTM	+16.19%
Atul Limited.	15,542	5,155.00	19.28	13.50%	+18.15% TTM	+40.10% TTM	-12.49%
Sudeep Pharma Limited	13,449	1,120.60	67.10	24.20%	—	—	—
Anupam Rasayan India Limited	13,117	1,144.40	57.92	7.50%	+51.76% TTM	+14.65% TTM	+6.58%
BASF India Ltd	12,838	2,959.95	21.44	13.10%	+13.35% TTM	+59.30% TTM	-33.46%
PRIVI SPECIALITY CHEMICALS LIMITED	12,792	3,283.30	34.73	25.10%	+17.54% TTM	+44.15% TTM	+10.09%
Vinati Organics Ltd.	10,462	996.85	25.09	17.70%	+10.98% TTM	-5.48% TTM	-39.90%
Elantas Beck India Ltd S	9,785	12,774.65	54.20	—	+18.86% TTM	+35.25% TTM	+29.29%
Jubilant Ingrevia Limited	9,269	562.35	25.55	10.80%	+15.41% TTM	+21.73% TTM	-18.43%
Alkyl Amines Chemicals Ltd. S	8,012	1,585.25	32.77	14.60%	+13.38% TTM	+35.83% TTM	-13.31%
Galaxy Surfactants Limited	7,678	2,269.80	22.75	12.70%	+27.05% TTM	+16.13% TTM	+0.01%
Neogen Chemicals Limited	7,237	2,268.40	168.60	6.80%	+26.66% TTM	+55.16% TTM	+54.05%
Clean Science and Technology Limited	7,224	656.60	29.92	19.20%	+4.51% TTM	-12.06% TTM	-33.34%
Fineotex Chemical Limited	6,227	53.42	41.98	16.20%	+91.44% TTM	+41.07% TTM	+84.27%
Balaji Amines Ltd.	5,814	1,770.80	23.80	10.20%	+20.91% TTM	+66.05% TTM	+26.00%
Archean Chemical Industries Limited	5,246	428.60	54.04	7.80%	+5.99% TTM	-42.66% TTM	-34.05%
Prasol Chemicals Limited	4,736	776.20	—	—	—	—	—
Laxmi Organic Industries Limited	4,654	161.95	35.81	4.40%	+5.47% TTM	+25.01% TTM	-17.12%
Foseco India Ltd S	4,568	5,962.25	57.00	—	+10.33% TTM	-3.71% TTM	+5.42%
EIKO LIFESCIENCES LIMITED	75	50.81	13.03	10.00%	+56.14% TTM	+86.93% TTM	-18.09%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. The Unaudited Standalone ....2 Nov 2026 · Board Meeting / Board Meeting
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lenus Finvest Pvt Ltd19 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Board of Directors of the Company vide Circular Resolution today, i.e. Friday, 16th October, 2026, considered and approved the allotment of equity shares on conversion of 1,50,000 (One ....16 Oct 2026 · Company Update / Allotment of Equity Shares
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Half Year ended on 30th September, 2026 received from M/s. Bigshare Services Pvt. Ltd., ....12 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to SEBI (PIT) Regulations, 2015 as amended and as per Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for dealing ....24 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
With refrence to the 49th Annual General Meeting of the Company held on Tuesday, 22nd September, 2026 at 04:00 P.M. IST through Video Conference/ Other Audio Visual Means, please find attached ....23 Sep 2026 · AGM/EGM / AGM
The Proceedings of the 49th Annual General Meeting (AGM) of Eiko LifeSciences Limited held on Tuesday, 22nd September, 2026 at 04:00 P.M. IST through Video Conferencing ('VC')/ Other Audio-Visual ....22 Sep 2026 · AGM/EGM / AGM
The Company has sent a letter providing the weblink and QR Code for accessing the Notice convening the 49th Annual General Meeting ("AGM") and the Annual Report of the Company for the Financial ....27 Aug 2026 · Company Update / General
Newspaper Advertisement for 49th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday, 22nd day of September, 2026 at 04:00 P.M. IST through Video Conference / Other ....25 Aug 2026 · Company Update / Newspaper Publication
Pursuant to provision of Regulations 30 and 34 of the SEBI LODR Regulations, 2015, we wish to inform that the 49th Annual General Meeting of the Company will be held on Tuesday, 22nd day ....24 Aug 2026 · Others / Reg. 34 (1) Annual Report
Pursuant to provision of Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the 49th Annual General Meeting of ....24 Aug 2026 · AGM/EGM / AGM
The Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August, 2026, Board, inter-alia, considered the following: 1. Noting of resignation of Ms. Hasti ....24 Aug 2026 · Company Update / Resignation of Director
Appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing Annual General ....24 Aug 2026 · Company Update / Change in Management
Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August, 2026, Board, inter-alia, considered the following: 1. Noting of resignation of Ms. Hasti Doshi ....24 Aug 2026 · Others / Outcome without intimation
As per PDF attached.18 Aug 2026 · Company Update / General
Disclosure of Conversion of 305000 Warrants into Equity Shares belonging to Promoter and Non Promoter Category18 Aug 2026 · Company Update / Allotment of Equity Shares
Pursuant to Regulations 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, The copy of newspaper publication in the following ....13 Aug 2026 · Company Update / Newspaper Publication
Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments ....12 Aug 2026 · Board Meeting / Outcome of Board Meeting
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve The Unaudited Standalone ....7 Aug 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 202613 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Trading Window shall remain closed for designated persons and their immediate relatives from Wednesday, 01st July, 2026 till 48 hours after the date of Board Meeting wherein, inter-alia, ....24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper publication dated 27th May, 2026 for Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended 31st March, 2026 approved by the Board ....27 May 2026 · Company Update / Newspaper Publication
Re-appointment of M/s NP Rajput & Co as Internal Auditor for FY 2026-27, at the Board Meeting held on 26th May, 2026.26 May 2026 · Company Update / Change in Management
Audited Financial Results (Standalone and Consolidated) for quarter and year ended 31st March, 202626 May 2026 · Board Meeting / Outcome of Board Meeting
Annual Secretarial Compliance Report for the year ended on 31st March 2026.25 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve The Audited Standalone and ....21 May 2026 · Board Meeting / Board Meeting
In view of SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018 and amendments thereto (the said Circular), we wish to inform you that as on 31st March, 2026, Eiko Lifesciences ....9 Apr 2026 · Company Update / General
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and year ended on 31st March, 2026 received from M/s. Bigshare Services Pvt. ....8 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and as per Company's Code of Conduct for Regulating, Monitoring and ....25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh Dhirajlal Tanna26 Feb 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lenus Finvest Pvt Ltd26 Feb 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Allotment of 6,25,000 Equity Shares and 29,50,000 Warrants on preferential basis under SEBI (ICDR) Regulations, 2018 through Circulation on Tuesday, 24th February, 202624 Feb 2026 · Company Update / Allotment of Equity Shares
Newspaper publication of Un-audited Financial results (standalone & Consolidated) for Quarter and Nine- Months ended on 31st December, 2025.30 Jan 2026 · Company Update / Newspaper Publication
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments thereto, ....29 Jan 2026 · Board Meeting / Outcome of Board Meeting
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider and approve Unaudited standalone and ....16 Jan 2026 · Board Meeting / Board Meeting
Certificate under Regulation. 74(5) of SEBI DP Act 2018 for the Quarter ended 31st December, 2025.9 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Combined e-voting results along with Scrutinizer Report.9 Jan 2026 · AGM/EGM / EGM
Outcome of 01st Extra-Ordinary General Meeting of Eiko Lifesciences Limited held on 07th January, 20267 Jan 2026 · AGM/EGM / EGM
The Promoter Group Entity M/s Lenus Finvest Private Limited received an adjudication order dated 05/01/2026 from SEBI for the alleged non-compliance with Regulation 31 of SAST Regulations ....5 Jan 2026 · Company Update / General
Closure of Trading Window for quarter ending 31st December, 202526 Dec 2025 · Insider Trading / SAST / Closure of Trading Window

Board meetings

5 Nov 2026 Board Meeting - Financial Results
12 Aug 2026 Board Meeting - Financial Results